Sickle Cell Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: S53D21884A9DEN
Market Monitor Global

Abstracts

The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.

This report contains market size and forecasts of Sickle Cell in Global, including the following market information:

Global Sickle Cell Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Sickle Cell market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sickle Cell include Novartis, Bristol-Myers Squibb, Takeda, Bluebird Bio and Global Blood Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sickle Cell companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sickle Cell Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Sickle Cell Market Segment Percentages, by Type, 2021 (%)

• Diagnosis
• Treatment

Global Sickle Cell Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Sickle Cell Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global Sickle Cell Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Sickle Cell Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Sickle Cell revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Sickle Cell revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Bristol-Myers Squibb
• Takeda
• Bluebird Bio
• Global Blood Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Sickle Cell Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Sickle Cell Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SICKLE CELL OVERALL MARKET SIZE

2.1 Global Sickle Cell Market Size: 2021 VS 2028
2.2 Global Sickle Cell Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Sickle Cell Players in Global Market
3.2 Top Global Sickle Cell Companies Ranked by Revenue
3.3 Global Sickle Cell Revenue by Companies
3.4 Top 3 and Top 5 Sickle Cell Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sickle Cell Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sickle Cell Players in Global Market
  3.6.1 List of Global Tier 1 Sickle Cell Companies
  3.6.2 List of Global Tier 2 and Tier 3 Sickle Cell Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Sickle Cell Market Size Markets, 2021 & 2028
  4.1.2 Diagnosis
  4.1.3 Treatment
4.2 By Type - Global Sickle Cell Revenue & Forecasts
  4.2.1 By Type - Global Sickle Cell Revenue, 2017-2022
  4.2.2 By Type - Global Sickle Cell Revenue, 2023-2028
  4.2.3 By Type - Global Sickle Cell Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Sickle Cell Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Sickle Cell Revenue & Forecasts
  5.2.1 By Application - Global Sickle Cell Revenue, 2017-2022
  5.2.2 By Application - Global Sickle Cell Revenue, 2023-2028
  5.2.3 By Application - Global Sickle Cell Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Sickle Cell Market Size, 2021 & 2028
6.2 By Region - Global Sickle Cell Revenue & Forecasts
  6.2.1 By Region - Global Sickle Cell Revenue, 2017-2022
  6.2.2 By Region - Global Sickle Cell Revenue, 2023-2028
  6.2.3 By Region - Global Sickle Cell Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Sickle Cell Revenue, 2017-2028
  6.3.2 US Sickle Cell Market Size, 2017-2028
  6.3.3 Canada Sickle Cell Market Size, 2017-2028
  6.3.4 Mexico Sickle Cell Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Sickle Cell Revenue, 2017-2028
  6.4.2 Germany Sickle Cell Market Size, 2017-2028
  6.4.3 France Sickle Cell Market Size, 2017-2028
  6.4.4 U.K. Sickle Cell Market Size, 2017-2028
  6.4.5 Italy Sickle Cell Market Size, 2017-2028
  6.4.6 Russia Sickle Cell Market Size, 2017-2028
  6.4.7 Nordic Countries Sickle Cell Market Size, 2017-2028
  6.4.8 Benelux Sickle Cell Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Sickle Cell Revenue, 2017-2028
  6.5.2 China Sickle Cell Market Size, 2017-2028
  6.5.3 Japan Sickle Cell Market Size, 2017-2028
  6.5.4 South Korea Sickle Cell Market Size, 2017-2028
  6.5.5 Southeast Asia Sickle Cell Market Size, 2017-2028
  6.5.6 India Sickle Cell Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Sickle Cell Revenue, 2017-2028
  6.6.2 Brazil Sickle Cell Market Size, 2017-2028
  6.6.3 Argentina Sickle Cell Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Sickle Cell Revenue, 2017-2028
  6.7.2 Turkey Sickle Cell Market Size, 2017-2028
  6.7.3 Israel Sickle Cell Market Size, 2017-2028
  6.7.4 Saudi Arabia Sickle Cell Market Size, 2017-2028
  6.7.5 UAE Sickle Cell Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Sickle Cell Major Product Offerings
  7.1.4 Novartis Sickle Cell Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Sickle Cell Major Product Offerings
  7.2.4 Bristol-Myers Squibb Sickle Cell Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Takeda
  7.3.1 Takeda Corporate Summary
  7.3.2 Takeda Business Overview
  7.3.3 Takeda Sickle Cell Major Product Offerings
  7.3.4 Takeda Sickle Cell Revenue in Global Market (2017-2022)
  7.3.5 Takeda Key News
7.4 Bluebird Bio
  7.4.1 Bluebird Bio Corporate Summary
  7.4.2 Bluebird Bio Business Overview
  7.4.3 Bluebird Bio Sickle Cell Major Product Offerings
  7.4.4 Bluebird Bio Sickle Cell Revenue in Global Market (2017-2022)
  7.4.5 Bluebird Bio Key News
7.5 Global Blood Therapeutics
  7.5.1 Global Blood Therapeutics Corporate Summary
  7.5.2 Global Blood Therapeutics Business Overview
  7.5.3 Global Blood Therapeutics Sickle Cell Major Product Offerings
  7.5.4 Global Blood Therapeutics Sickle Cell Revenue in Global Market (2017-2022)
  7.5.5 Global Blood Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Sickle Cell Market Opportunities & Trends in Global Market
Table 2. Sickle Cell Market Drivers in Global Market
Table 3. Sickle Cell Market Restraints in Global Market
Table 4. Key Players of Sickle Cell in Global Market
Table 5. Top Sickle Cell Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sickle Cell Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sickle Cell Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sickle Cell Product Type
Table 9. List of Global Tier 1 Sickle Cell Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sickle Cell Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sickle Cell Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sickle Cell Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sickle Cell Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sickle Cell Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sickle Cell Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sickle Cell Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sickle Cell Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sickle Cell Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sickle Cell Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sickle Cell Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sickle Cell Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sickle Cell Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sickle Cell Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sickle Cell Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sickle Cell Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sickle Cell Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sickle Cell Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sickle Cell Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sickle Cell Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Sickle Cell Product Offerings
Table 32. Novartis Sickle Cell Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Sickle Cell Product Offerings
Table 35. Bristol-Myers Squibb Sickle Cell Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Corporate Summary
Table 37. Takeda Sickle Cell Product Offerings
Table 38. Takeda Sickle Cell Revenue (US$, Mn), (2017-2022)
Table 39. Bluebird Bio Corporate Summary
Table 40. Bluebird Bio Sickle Cell Product Offerings
Table 41. Bluebird Bio Sickle Cell Revenue (US$, Mn), (2017-2022)
Table 42. Global Blood Therapeutics Corporate Summary
Table 43. Global Blood Therapeutics Sickle Cell Product Offerings
Table 44. Global Blood Therapeutics Sickle Cell Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Sickle Cell Segment by Type in 2021
Figure 2. Sickle Cell Segment by Application in 2021
Figure 3. Global Sickle Cell Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sickle Cell Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sickle Cell Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sickle Cell Revenue in 2021
Figure 8. By Type - Global Sickle Cell Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sickle Cell Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sickle Cell Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sickle Cell Revenue Market Share, 2017-2028
Figure 12. US Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sickle Cell Revenue Market Share, 2017-2028
Figure 16. Germany Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 17. France Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sickle Cell Revenue Market Share, 2017-2028
Figure 24. China Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 28. India Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sickle Cell Revenue Market Share, 2017-2028
Figure 30. Brazil Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sickle Cell Revenue Market Share, 2017-2028
Figure 33. Turkey Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sickle Cell Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Sickle Cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Sickle Cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Sickle Cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bluebird Bio Sickle Cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Global Blood Therapeutics Sickle Cell Revenue Year Over Year Growth (US$, Mn) & (2017-2022)